Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures

NCT: NCT03568292 · SUSPENDED

NCT IDNCT03568292
StatusSUSPENDED
Start Date2022-03-01
Completion2027-03-01

Brief Summary

This trial studies how well virtual reality (VR) works in reducing pain and anxiety in cancer participants undergoing bone marrow biopsy or lumbar puncture. Virtual reality may impact pain and anxiety during and after the procedure.

Frequently Asked Questions

What is Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures?

Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures is a clinical trial registered under NCT03568292. Current status: SUSPENDED.

What is the status of NCT03568292?

The current status of NCT03568292 (Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures) is: SUSPENDED.

When did Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures start?

Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures started on 2022-03-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑